Atlas Trials

Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study

Clinical trial NCT00362765 · TERMINATED

Trial details

NCT number
NCT00362765
Sponsor
Solvay Pharmaceuticals
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Type 2 DiabetesDyslipidemia
Start date
2006-10-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.